MRI back pain data won't change treatment results
The presence of common structural abnormalities identified by MRI in chronic nonspecific low back pain patients has no bearing on their responses to conservative treatment, according to a signficant study published in the journal Spine.
The presence of common structural abnormalities identified by MRI in chronic nonspecific low back pain patients has no bearing on their responses to conservative treatment, according to a signficant study published in the journal Spine.
Dr. Frank Kleinstuck and colleagues at the Schulthess Klinik's Spine Unit in Zurich prospectively obtained T2-weighted, 4-mm spin-echo MRI sequences of the lumbar spine of 53 chronic nonspecific low back pain patients prior to participation in a three-month exercise therapy program. They analyzed the presence or absence of abnormalities in relation to disability and back pain level (average to worst) before beginning the program, after its completion, and 12 months later. They found an association only between MRI-detected high-intensity zones and lower average pain at the 12-month follow-up.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
